Antara Mallampalli , Ritwick Agrawal , Supriya Singh , Lequan Dang , Shahram Moghtader , Kanta Velamuri , Tara Thomas , Amir Sharafkhaneh
{"title":"Initial experience and establishment of a hypersomnia board: A multidisciplinary approach to complex hypersomnia cases","authors":"Antara Mallampalli , Ritwick Agrawal , Supriya Singh , Lequan Dang , Shahram Moghtader , Kanta Velamuri , Tara Thomas , Amir Sharafkhaneh","doi":"10.1016/j.sleep.2025.106735","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Hypersomnia disorders are complex both diagnostically and management wise. Complex medical conditions benefit from multidisciplinary board (MDB). We describe the structure, implementation, and preliminary outcomes of a hypersomnia MDB established to improve diagnosis and management of complex hypersomnia cases.</div></div><div><h3>Methods</h3><div>We implemented a monthly virtual case-based conference at a large VA medical center, involving clinicians from sleep medicine, psychiatry, neurology, clinical psychology, and pharmacy. Patients with central hypersomnia disorders, diagnostic uncertainty, or management challenges were selected for discussion. Presenting providers summarized patient histories, diagnostics, and treatment concerns. A multidisciplinary group reviewed each case, and consensus recommendations were documented in the electronic health record.</div></div><div><h3>Results</h3><div>Over two years, 33 unique patients were presented. Final diagnoses included narcolepsy type 1 (9/33), narcolepsy type 2 (9/33), idiopathic hypersomnia (6/33), and primary obstructive sleep apnea (6/33). Comorbid mental illness (e.g., depression in 15/33, post-traumatic stress disorder or PTSD in 9/33) and obstructive sleep apnea (18/33) were common. The board recommended medication changes in 8/33 patients, mental health referrals in 5/33, and further diagnostic testing in 8/33. Clinician feedback indicated improved diagnostic clarity, enhanced collaboration, and educational benefit, especially for sleep medicine trainees.</div></div><div><h3>Conclusions</h3><div>Establishing a hypersomnia MDB is feasible and promotes collaborative care, improves diagnostic accuracy and treatment plans for patients with complex hypersomnia, and enhances trainee education. Future directions include measuring treatment outcomes, assessing care barriers, tracking clinical responses over time, and expanding to larger scale operations.</div></div>","PeriodicalId":21874,"journal":{"name":"Sleep medicine","volume":"134 ","pages":"Article 106735"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1389945725004101","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Hypersomnia disorders are complex both diagnostically and management wise. Complex medical conditions benefit from multidisciplinary board (MDB). We describe the structure, implementation, and preliminary outcomes of a hypersomnia MDB established to improve diagnosis and management of complex hypersomnia cases.
Methods
We implemented a monthly virtual case-based conference at a large VA medical center, involving clinicians from sleep medicine, psychiatry, neurology, clinical psychology, and pharmacy. Patients with central hypersomnia disorders, diagnostic uncertainty, or management challenges were selected for discussion. Presenting providers summarized patient histories, diagnostics, and treatment concerns. A multidisciplinary group reviewed each case, and consensus recommendations were documented in the electronic health record.
Results
Over two years, 33 unique patients were presented. Final diagnoses included narcolepsy type 1 (9/33), narcolepsy type 2 (9/33), idiopathic hypersomnia (6/33), and primary obstructive sleep apnea (6/33). Comorbid mental illness (e.g., depression in 15/33, post-traumatic stress disorder or PTSD in 9/33) and obstructive sleep apnea (18/33) were common. The board recommended medication changes in 8/33 patients, mental health referrals in 5/33, and further diagnostic testing in 8/33. Clinician feedback indicated improved diagnostic clarity, enhanced collaboration, and educational benefit, especially for sleep medicine trainees.
Conclusions
Establishing a hypersomnia MDB is feasible and promotes collaborative care, improves diagnostic accuracy and treatment plans for patients with complex hypersomnia, and enhances trainee education. Future directions include measuring treatment outcomes, assessing care barriers, tracking clinical responses over time, and expanding to larger scale operations.
期刊介绍:
Sleep Medicine aims to be a journal no one involved in clinical sleep medicine can do without.
A journal primarily focussing on the human aspects of sleep, integrating the various disciplines that are involved in sleep medicine: neurology, clinical neurophysiology, internal medicine (particularly pulmonology and cardiology), psychology, psychiatry, sleep technology, pediatrics, neurosurgery, otorhinolaryngology, and dentistry.
The journal publishes the following types of articles: Reviews (also intended as a way to bridge the gap between basic sleep research and clinical relevance); Original Research Articles; Full-length articles; Brief communications; Controversies; Case reports; Letters to the Editor; Journal search and commentaries; Book reviews; Meeting announcements; Listing of relevant organisations plus web sites.